Modern life sciences organizations are inherently complex. What is adding further stress to these companies and their often stretched accounting teams is the increasingly complicated nature of biotech accruals. Whether it’s confusing clinical trial accrual methodologies, a lack of transparency and access to information, or the reliance on estimates and assumptions, it has never been more difficult to be confident in your accruals.

In this on-demand webinar, Billy Tamulynas (Sikich Finance Automation Expert) and Jotham Ty (CEO/Founder of Gappify) discuss accrual best practices to help Biotech and Life Sciences companies determine:

• Who should own accruals within an organization
• What types of accruals to run
• What factors to consider when deciding on an AP module close date